These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35613867)

  • 1. Is intravenous immunoglobulin a risk factor for necrotizing enterocolitis in neonates with haemolytic disease of the newborn? A retrospective cohort study.
    Li J; Zhong XY; Song SJ; Liao LF; Wu Y
    Vox Sang; 2022 Sep; 117(9):1098-1104. PubMed ID: 35613867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease.
    Figueras-Aloy J; Rodríguez-Miguélez JM; Iriondo-Sanz M; Salvia-Roiges MD; Botet-Mussons F; Carbonell-Estrany X
    Pediatrics; 2010 Jan; 125(1):139-44. PubMed ID: 19948572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necrotizing enterocolitis in haemolytic disease of the newborn: a retrospective cohort study.
    Ree IMC; de Grauw AM; Bekker V; de Haas M; Te Pas AB; Oepkes D; Middeldorp AJM; Lopriore E
    Vox Sang; 2020 Feb; 115(2):196-201. PubMed ID: 31858620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease.
    Corvaglia L; Legnani E; Galletti S; Arcuri S; Aceti A; Faldella G
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2782-5. PubMed ID: 22882154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for surgical treatment in preterm neonates with necrotizing enterocolitis: a multicenter case-control study.
    El Manouni El Hassani S; Niemarkt HJ; Derikx JPM; Berkhout DJC; Ballón AE; de Graaf M; de Boode WP; Cossey V; Hulzebos CV; van Kaam AH; Kramer BW; van Lingen RA; Vijlbrief DC; van Weissenbruch MM; Benninga MA; de Boer NKH; de Meij TGJ
    Eur J Pediatr; 2021 Feb; 180(2):617-625. PubMed ID: 33269424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2004; (1):CD000361. PubMed ID: 14973955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2001; (2):CD000361. PubMed ID: 11405962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent ductus arterious and increased conjugated bilirubin in the second week after birth are independent risk factors for necrotizing enterocolitis in preterm infants: an observational study.
    Han X; Cui S
    BMC Pediatr; 2023 Jul; 23(1):356. PubMed ID: 37442980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in neonates with necrotizing enterocolitis and patent ductus arteriosus.
    Kessler U; Schulte F; Cholewa D; Nelle M; Schaefer SC; Klimek PM; Berger S
    World J Pediatr; 2016 Feb; 12(1):55-9. PubMed ID: 26684305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of neutrophil to lymphocyte ratio with preterm necrotizing enterocolitis: a retrospective case-control study.
    Mu Y; Wang H
    BMC Gastroenterol; 2022 May; 22(1):248. PubMed ID: 35581541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for mortality in preterm infants with necrotizing enterocolitis: a retrospective multicenter analysis.
    Kordasz M; Racine M; Szavay P; Lehner M; Krebs T; Luckert C; Hau EM; Berger S; Kessler U
    Eur J Pediatr; 2022 Mar; 181(3):933-939. PubMed ID: 34636956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal and Placental Risk Factors for Developing Necrotizing Enterocolitis in Very Preterm Infants.
    Lee JY; Park KH; Kim A; Yang HR; Jung EY; Cho SH
    Pediatr Neonatol; 2017 Feb; 58(1):57-62. PubMed ID: 27328638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth weight neonates.
    Foster JP; Seth R; Cole MJ
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001816. PubMed ID: 27040323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study comparing short-term outcome in preterm infants of ≤30 weeks gestation between a tertiary neonatal care unit in Bangalore, India and one in London, UK.
    Diggikar S; Nagesh NK; Kumar NA; Aladangady N
    Paediatr Int Child Health; 2022 Feb; 42(1):5-11. PubMed ID: 35400315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunoglobulin for preventing necrotizing enterocolitis in preterm and low birth-weight neonates.
    Foster J; Cole M
    Cochrane Database Syst Rev; 2001; (3):CD001816. PubMed ID: 11686997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of delivery and necrotizing enterocolitis in very preterm very-low-birth-weight infants.
    Riskin A; Riskin-Mashiah S; Itzchaki O; Bader D; Zaslavsky-Paltiel I; Lerner-Geva L; Reichman B;
    J Matern Fetal Neonatal Med; 2021 Dec; 34(23):3933-3939. PubMed ID: 31847646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.
    Kara S; Ulu-ozkan H; Yilmaz Y; Arikan FI; Dilmen U; Bilge YD
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):598-600. PubMed ID: 23930883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for the surgical treatment of necrotizing enterocolitis in preterm infants: a single-center retrospective study.
    Liu Y; Qiao L; Wu X; Jiang Z; Hao X
    BMC Pediatr; 2022 Jan; 22(1):9. PubMed ID: 34980023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: a retrospective 11-year study.
    Lieberman L; Spradbrow J; Keir A; Dunn M; Lin Y; Callum J
    Transfusion; 2016 Nov; 56(11):2704-2711. PubMed ID: 27459953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants.
    Ohlsson A; Lacy JB
    Cochrane Database Syst Rev; 2013 Jul; (7):CD000361. PubMed ID: 23821390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.